Vaccine, Brazil, Sputnik V

Vaccine, Brazil

Brazilian firm to produce Russian vaccine without regulatory approval

Brazilian firm to produce Russian vaccine without regulatory approval

7/5/2021 10:16:00 PM

Brazil ian firm to produce Russian vaccine without regulatory approval

The Brazil ian pharmaceutical company that plans to produce Russia's Sputnik V coronavirus vaccine will start making it next week even before ...

WorldFILE PHOTO: A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia, January 18, 2021 REUTERS/Shamil Zhumatov/File Photo08 May 2021 02:53AMShare this contentBookmarkBRASILIA: The Brazilian pharmaceutical company that plans to produce Russia's Sputnik V coronavirus vaccine will start making it next week even before health regulator Anvisa gives approval for use in Brazil, the company's chief executive said on Friday (May 7).

Visits to hospital wards to be suspended for 4 weeks as more COVID-19 cases detected among staff, patients and visitors Singapore reports 1,453 new local COVID-19 cases, 3 more deaths Record high of 1,457 new COVID cases reported in Singapore; 3 more deaths

União Quimica's facility in São Paulo has been certified by Anvisa for good production practices and the vaccine will be made for export to countries that have approved it, said CEO and founder Fernando Marques.AdvertisementAdvertisement

"We intend to start production next week with a view to export," Marques said. He said Sputnik V will not be used in Brazil until it is approved, but neighboring Latin American countries have approved the vaccine and want deliveries.Anvisa last week held off approving imports of Sputnik V sought by Brazilian state governors amid a second wave of the virus that has killed more than 415,000 Brazilians. headtopics.com

In a setback for the Russian vaccine, the regulator's technical staff warned of"flaws" in the development and clinical testing of Sputnik, said the data presented on the vaccine's safety and efficacy was incomplete.Marques on Friday told a Senate commission on COVID-19 that União Quimica expects to receive a batch of active ingredient from Moscow next week to start making the vaccine for export at its plant near São Paulo's Guarulhos airport.

AdvertisementAdvertisement"So, the situation today is this: we will start production, obviously when we receive the active ingredient, and we will wait for the registration to make the local production available for use in Brazil," he told senators.

The Russian Direct Investment Fund that is marketing Sputnik V developed by Russia's Gamaleya Research Institute has plans to supply the vaccine to Latin American countries from Brazil. Read more: CNA »

Covid-19: People with positive rapid-test result to self-isolate for 3 days; test kits at 100 vending machines from Sept 18

US says 'Russia-based' group DarkSide behind pipeline hackPresident Joe Biden said on Monday (May 10) that a Russia-based group was behind the ransomware attack that forced the shutdown of the largest oil ...

Russia slams US proposal for 'summit for democracy'Russian Foreign Minister Sergei Lavrov on Friday attacked a US proposal to hold a 'Summit for Democracy,' saying such a gathering would only ...

Blinken presses Russia to pull troops on solidarity trip to UkraineUS Secretary of State Antony Blinken on Thursday demanded that Russia end its 'aggressive' actions towards Ukraine, warning on a solidarity visit ...

A 101 carat diamond –the largest ever cut in Russia – to be auctioned offCalled the Alrosa Spectacle, the diamond is expected to fetch between 12 and 18 million Swiss francs (S$26.44 million) when it goes under the hammer at Christie's on May 12. wow!

Merkel hopeful on Europe summer travel even without COVID-19 vaccineMerkel hopeful on Europe summer travel even without vaccine 沒有抗體感染了新冠病毒,就會把病毒傳播開來。